ClinicalTrials.Veeva

Menu

Pulsed Short Wave Therapy In Cesarean Section

B

BioElectronics Corporation

Status

Unknown

Conditions

Postoperative Pain

Treatments

Device: RecoveryRx
Device: Sham RecoveryRx

Study type

Interventional

Funder types

Industry

Identifiers

NCT03604068
PRO180401

Details and patient eligibility

About

This clinical study is designed to assesses the benefit of adding pulsed shortwave therapy to the postoperative pain and recovery protocol following Cesarean section. Pulsed shortwave therapy is a safe adjunct pain therapy for acute and chronic pain.

Full description

Pain is ranked highest among undesirable clinical outcomes associated with caesarean section therefore postoperative pain relief following a cesarean section is extremely important to optimize maternal and neonate well being. Multimodial analgesics are effective in reducing postoperative pain but analgesia is still not optimized. Opiate based analgesics are effective but having troubling side effects. Addition of non-drug pain therapies hold promise in improving postoperative recovery while potentially allowing for reduced use of drug based analgesics.

Enrollment

250 estimated patients

Sex

Female

Ages

18 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Voluntarily
  • Performed using spinal anesthesia
  • ASA I (Normal healthy patients) and II (Patients with mild systemic disease) (as defined by the American Society of Anesthesiologists Physical Status Classification system)
  • PARA 0000, 1, 2, 3 [i.e. First, Second, or Third C-Section)
  • At term pregnancy (>38 weeks)
  • BMI <35
  • Age between 18 - 50 years

Exclusion criteria

  • Longitudinal surgical incision
  • Placental abnormalities noted
  • Time of extraction of the fetus >10 min from cutaneous incision
  • Blood loss during surgery of >800 ml
  • Any of the conditions not considered in inclusion criteria

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

250 participants in 2 patient groups

Active Group
Active Comparator group
Description:
Patients in this group will be treated with the currently used standard protocol for the control of post-operative pain as well as an active RecoveryRx Pulsed Short Wave Therapy device.
Treatment:
Device: RecoveryRx
Control Group
Sham Comparator group
Description:
Patients in this group will be treated with the currently used standard protocol for the control of post-operative pain as well as a sham RecoveryRx Pulsed Short Wave Therapy device.
Treatment:
Device: Sham RecoveryRx

Trial contacts and locations

2

Loading...

Central trial contact

Mahmoud Maassarani, Ph.D; Omar Tabbouche, Pharma D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems